PE110398A1 - Productos intermedios y proceso para preparar olanzapina - Google Patents
Productos intermedios y proceso para preparar olanzapinaInfo
- Publication number
- PE110398A1 PE110398A1 PE1997000855A PE00085597A PE110398A1 PE 110398 A1 PE110398 A1 PE 110398A1 PE 1997000855 A PE1997000855 A PE 1997000855A PE 00085597 A PE00085597 A PE 00085597A PE 110398 A1 PE110398 A1 PE 110398A1
- Authority
- PE
- Peru
- Prior art keywords
- olanzapine
- polymorph
- methyl
- refers
- intermediate products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Abstract
SE REFIERE AL PROCEDIMIENTO DE PREPARACION DEL 2-METIL-4-(4-METIL-1-PIPERAZINIL)-1OH-TIENO[2,3-b][1,5]BENZODIAZEPINA (OLANZAPINA) DE FORMA II, QUE COMPRENDE: DESHIDRATAR UN DIHIDRATO DE OLANZAPINA EN UN VACUOHORNO A UNA TEMPERATURA ENTRE 40�C a 70�C. ESTE PROCESO PERMITE LA OBTENCION DE LA FORMA II (FORMA ANHIDRA MAS ESTABLE DE OLANZAPINA) SUSTANCIALMENTE PURA, QUE TENDRA APROXIMADAMENTE MENOS DE 0,5% DE IMPUREZAS QUIMICAS O SOLVENTES RESIDUALES INDESABLES. TAMBIEN SE REFIERE A LOS POLIMORFOS "B" Y "E" DEL DIHIDRATO DE OLANZAPINA; EN DONDE EL POLIMORFO "B" SE CARACTERIZA POR EL SIGUIENTE PATRON DE DIFRACCION DE RAYOS X: 9,9045 6,9985 6,763 6,4079 6,1548 6,0611 5,8933 5,6987 5,4395 5,1983 5,0843 4,9478 4,7941 4,696 4,5272 4,4351 4,3474 4,2657 4,1954 4,0555 3,9903 3,9244 3,8561 3,8137 3,7671 3,6989 3,6527 3,5665 3,4879 3,3911 3,3289 3,2316 3,1982 3,1393 3,0824 2,9899 2,9484 2,9081 2,8551 2,8324 2,751 2,7323 2,6787 2,6424 2,5937; Y EL POLIMORFO "E" SE CARACTERIZA POR EL SIGUIENTE PATRON DE DIFRACCION DE RAYOS X: 9,871 9,5514 6,9575 6,141 6,0644 5,9896 5,8774 4,7721 4,6673 4,5171 4,4193 4,354 4,2539 4,2369 4,0537 4,0129 3,8555 3,7974 3,6846 3,5541 3,4844 3,474 3,4637 3,3771 3,1245 2,9403. LA OLANZAPINA ES USADA EN EL TRATAMIENTO ANTIPSICOTICO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2648796P | 1996-09-23 | 1996-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE110398A1 true PE110398A1 (es) | 1999-01-14 |
Family
ID=21832120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1997000855A PE110398A1 (es) | 1996-09-23 | 1997-09-23 | Productos intermedios y proceso para preparar olanzapina |
Country Status (36)
Country | Link |
---|---|
US (1) | US6020487A (es) |
EP (1) | EP0831098B1 (es) |
JP (2) | JP2001500877A (es) |
KR (1) | KR100560015B1 (es) |
CN (1) | CN1122036C (es) |
AR (1) | AR013838A1 (es) |
AT (1) | ATE209208T1 (es) |
AU (1) | AU719441B2 (es) |
BR (1) | BR9712100A (es) |
CA (1) | CA2265712C (es) |
CO (1) | CO4910140A1 (es) |
CZ (1) | CZ299248B6 (es) |
DE (1) | DE69708428T2 (es) |
DK (1) | DK0831098T3 (es) |
EA (1) | EA001642B1 (es) |
EG (1) | EG23861A (es) |
ES (1) | ES2166051T3 (es) |
HK (1) | HK1009807A1 (es) |
HU (1) | HU226484B1 (es) |
ID (1) | ID27275A (es) |
IL (1) | IL128962A (es) |
IN (1) | IN187156B (es) |
MY (1) | MY125565A (es) |
NO (1) | NO323980B1 (es) |
NZ (1) | NZ334448A (es) |
PE (1) | PE110398A1 (es) |
PL (3) | PL196068B1 (es) |
PT (1) | PT831098E (es) |
RS (1) | RS49598B (es) |
SI (1) | SI0831098T1 (es) |
SV (1) | SV1997000081A (es) |
TR (1) | TR199900640T2 (es) |
TW (1) | TW470746B (es) |
UA (1) | UA59371C2 (es) |
WO (1) | WO1998012199A1 (es) |
ZA (1) | ZA978515B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2003566A3 (cs) * | 2000-08-31 | 2004-01-14 | Dr. Reddy's Laboratories Ltd. | Způsob přípravy hydrátů olanzapinu a jejich konverze na krystalické formy olanzapinu |
US6740753B2 (en) * | 2001-01-04 | 2004-05-25 | Geneva Pharmaceuticals, Inc. | Olanzapine crystal modification |
CA2464306A1 (en) * | 2001-10-29 | 2003-05-08 | Dr. Reddy's Laboratories Ltd. | Olanzapine dihydrate-ii a process for its preparation and use thereof |
CH695862A5 (fr) | 2001-12-24 | 2006-09-29 | Sun Pharmaceutical Ind Ltd | Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine. |
WO2003091260A1 (en) * | 2002-04-23 | 2003-11-06 | Dr. Reddy's Laboratories Limited | Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof |
SI1513846T1 (sl) | 2002-05-31 | 2011-11-30 | Sandoz Ag | Postopek za pripravo olanzapina form I |
SI21270A (sl) | 2002-07-15 | 2004-02-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Kristalne oblike olanzapina in postopki za njihovo pripravo |
US7323459B2 (en) | 2002-12-24 | 2008-01-29 | Teva Pharmaceutical Industries Ltd. | Crystal forms, methods for their preparation and method for preparation of olanzapine |
CA2546200A1 (en) * | 2003-11-18 | 2005-06-02 | 3M Innovative Properties Company | Olanzapine containing transdermal drug delivery compositions |
CA2551806A1 (en) * | 2003-12-22 | 2005-07-14 | Teva Pharmaceutical Industries, Ltd. | Methods of preparing olanzapine |
DE602005027308D1 (de) | 2004-01-27 | 2011-05-19 | Synthon Bv | Stabile salze von olanzapin |
WO2005080401A1 (en) * | 2004-02-19 | 2005-09-01 | Neuland Laboratories Limited | Process for the preparation of olanzapine form 1 useful as antipsychotic drug |
WO2006006185A1 (en) * | 2004-07-14 | 2006-01-19 | Shasun Chemicals And Drugs Limited | Improved process for making form i of olanzapine. |
ES2253091B1 (es) | 2004-07-27 | 2007-02-01 | Inke, S.A. | Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo. |
WO2006027800A1 (en) * | 2004-09-06 | 2006-03-16 | Shasun Chemicals And Drugs Limited | A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine |
EP2623095A1 (en) * | 2004-11-16 | 2013-08-07 | Elan Pharma International Limited | Injectable nanoparticulate olanzapine formulations |
US7834176B2 (en) | 2006-01-26 | 2010-11-16 | Sandoz Ag | Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E |
CA2591644A1 (en) * | 2007-06-14 | 2008-12-14 | Apotex Pharmachem Inc. | Novel processes to form-i of olanzapine |
EP2486913A1 (en) | 2011-02-14 | 2012-08-15 | Labtec GmbH | Rapidly disintegrating oral film formulation for Olanzapin |
JP6008734B2 (ja) * | 2012-12-20 | 2016-10-19 | 株式会社トクヤマ | オランザピンii型結晶の製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5302716A (en) * | 1986-01-16 | 1994-04-12 | Schering Corporation | Fused benzazepines |
CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
ES2153373T3 (es) * | 1992-05-29 | 2001-03-01 | Lilly Co Eli | Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central. |
US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
US5602124A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
ID21924A (id) * | 1996-09-23 | 1999-08-12 | Lilly Co Eli | Olanzapin dihidrat d |
-
1997
- 1997-09-02 ZA ZA978515A patent/ZA978515B/xx unknown
- 1997-09-18 EA EA199900326A patent/EA001642B1/ru not_active IP Right Cessation
- 1997-09-18 CN CN97198137A patent/CN1122036C/zh not_active Expired - Lifetime
- 1997-09-18 PL PL381479A patent/PL196068B1/pl unknown
- 1997-09-18 CZ CZ0099099A patent/CZ299248B6/cs not_active IP Right Cessation
- 1997-09-18 UA UA99031635A patent/UA59371C2/uk unknown
- 1997-09-18 HU HU0000066A patent/HU226484B1/hu unknown
- 1997-09-18 IL IL12896297A patent/IL128962A/xx not_active IP Right Cessation
- 1997-09-18 PL PL381478A patent/PL196069B1/pl unknown
- 1997-09-18 PL PL97332482A patent/PL194565B1/pl unknown
- 1997-09-18 ID IDW990058D patent/ID27275A/id unknown
- 1997-09-18 RS YUP-155/99A patent/RS49598B/sr unknown
- 1997-09-18 NZ NZ334448A patent/NZ334448A/en not_active IP Right Cessation
- 1997-09-18 AU AU44841/97A patent/AU719441B2/en not_active Expired
- 1997-09-18 WO PCT/US1997/016499 patent/WO1998012199A1/en not_active Application Discontinuation
- 1997-09-18 KR KR1019997002424A patent/KR100560015B1/ko not_active IP Right Cessation
- 1997-09-18 BR BR9712100-2A patent/BR9712100A/pt not_active Application Discontinuation
- 1997-09-18 TR TR1999/00640T patent/TR199900640T2/xx unknown
- 1997-09-18 CA CA002265712A patent/CA2265712C/en not_active Expired - Lifetime
- 1997-09-18 JP JP10514842A patent/JP2001500877A/ja not_active Withdrawn
- 1997-09-19 IN IN1736CA1997 patent/IN187156B/en unknown
- 1997-09-22 ES ES97307383T patent/ES2166051T3/es not_active Expired - Lifetime
- 1997-09-22 AT AT97307383T patent/ATE209208T1/de active
- 1997-09-22 SI SI9730288T patent/SI0831098T1/xx unknown
- 1997-09-22 MY MYPI97004392A patent/MY125565A/en unknown
- 1997-09-22 CO CO97055061A patent/CO4910140A1/es unknown
- 1997-09-22 EP EP97307383A patent/EP0831098B1/en not_active Expired - Lifetime
- 1997-09-22 DE DE69708428T patent/DE69708428T2/de not_active Expired - Lifetime
- 1997-09-22 DK DK97307383T patent/DK0831098T3/da active
- 1997-09-22 SV SV1997000081A patent/SV1997000081A/es not_active Application Discontinuation
- 1997-09-22 PT PT97307383T patent/PT831098E/pt unknown
- 1997-09-23 PE PE1997000855A patent/PE110398A1/es active IP Right Grant
- 1997-09-23 AR ARP970104362A patent/AR013838A1/es not_active Application Discontinuation
- 1997-09-23 US US08/935,884 patent/US6020487A/en not_active Expired - Lifetime
- 1997-09-23 EG EG98697A patent/EG23861A/xx active
-
1998
- 1998-02-27 TW TW086113832A patent/TW470746B/zh not_active IP Right Cessation
- 1998-09-21 HK HK98110796A patent/HK1009807A1/xx not_active IP Right Cessation
-
1999
- 1999-03-22 NO NO19991382A patent/NO323980B1/no not_active IP Right Cessation
-
2009
- 2009-06-05 JP JP2009135901A patent/JP2009242407A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE110398A1 (es) | Productos intermedios y proceso para preparar olanzapina | |
ES2112971T3 (es) | Procedimiento para el tratamiento de fibras para la fabricacion de papel de seda. | |
DK0751129T3 (da) | Substituerede dihydrodibenz/b,f/azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle li | |
TR199902538T2 (xx) | Yeni bile�imler. | |
YU44900A (sh) | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola | |
ES2106700T3 (es) | Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas. | |
NO913689L (no) | Fremgangsmaate ved fremstilling av silisiumbarrer med hoey renhet. | |
IL147162A0 (en) | Process for the preparation of pure citalopram | |
NO160579C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-(1,4,5-trifenylimidazol-2-yloksy)-alkansyrer og disses derivater. | |
DE69017789T2 (de) | 1,2,3,4-Tetrahydro-9-Akridinaminderivate. | |
NO178968C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater | |
ES2091324T3 (es) | Proceso para la preparacion de aspartama a partir de una dicetopiperazina y nuevos compuestos intermedios y derivados para dicho proceso. | |
RO77280A (ro) | Procedeu pentru prepararea unor izocianati aromatici de inalta puritate | |
ES2071303T3 (es) | Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes. | |
PT91414A (pt) | Processo para a preparacao de 2-fenil-1,2-benzisosselenazol-3(2h)-ona(ebseleno) sob uma forma muito pura | |
PE38197A1 (es) | Procedimiento para preparar solvatos de 2-metil-tieno-benzodiacepina (olanzapina) | |
FI885560A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
NO892435D0 (no) | Analogifremgangsmaate for fremstilling av 4,5,7,8-tetrahydro-6h-tiazolo (5,4-d)- azepiner. | |
NO174423C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tieno(3,2-b)pyraner | |
ES2092785T3 (es) | Nuevo procedimiento de preparacion de compuestos esteroides de 20-ceto-21alfa-hidroxi y productos intermedios. | |
NO905364D0 (no) | Fremgangsmaate ved fremstilling av alkansyrederivater. | |
ES2053590T3 (es) | 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados. | |
ZA907976B (en) | Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof | |
FI910159A0 (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9a-hydroxi-3-oxo-4,24(25)-stigmastadien-26 -syraderivat. | |
JPS53123669A (en) | Wafer holding method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |